ENCEFALOPATIA DE HASHIMOTO PDF

Hashimoto encephalopathy (HE) is an uncommon syndrome associated with Hashimoto thyroiditis Cantón A, de Fàbregas O, Tintoré M, et al. Request PDF on ResearchGate | On Jun 1, , Paloma Bacarizo and others published Encefalopatía de Hashimoto en un paciente de 20 años. CLINICAL/SCIENTIFIC NOTE. Hashimoto’s encephalopathy. Encefalite de Hashimoto. Renata Telles Rudge de AquinoI; Eduardo Genaro MutarelliII.

Author: Yozshubar Tarn
Country: Liechtenstein
Language: English (Spanish)
Genre: Business
Published (Last): 10 December 2010
Pages: 264
PDF File Size: 18.29 Mb
ePub File Size: 20.64 Mb
ISBN: 264-8-12564-522-2
Downloads: 26227
Price: Free* [*Free Regsitration Required]
Uploader: Faerisar

Hashimoto’s encephalopathy – Wikipedia

There followed a period of three years with difficulties at school. She had a 6 month history of behavioral changes and agitation, resulting in psychiatric treatment of estazolan 2 mg, bupropion mg, carbamazepine mg and duoxetine 30 mg daily. The presence of antithyroglobulin antibody Ac-anti-Tg was not encefaloptia.

Received 18 Junereceived in final form 1 September Duration of treatment is usually between 2 and 25 years.

Hashimoto’s encephalopathy

We describe the case of a patient with Hashimoto’s encephalopathy who showed clinical manifestations similar to those of Creutzfeldt-Jakob disease. Thyroid hormone treatment is also included if required. J Clin Endocrinol Metab ; At present, it is unclear whether antithyroid antibodies represent encefalopafia immune epiphenomenon in a subset of patients with encephalopathic processes or they are really associated with pathogenic mechanisms of the disorder. The levels of triiodothyronine T3 and free thyroxine T4 L were within normal limits.

Prominent triphasic waves, focal slowing, epileptiform abnormalities, photoparoxysmal and photomyogenic responses may be seen. She had a 2 years history of feeling progressively tired, insomnia, cramps, tremors, arthralgia, paraethesia in her hands and back pain.

The correlation between anti-TPO and initial clinical progress observed was seen in some cases 8. In this case, the Hashimoto’s encephalopathy diagnosis was made based on the exclusion of other toxic-metabolic encephalopathic and neurological diseases of infectious or vascular origin, and on the detection of high concentrations of anti-TPO antibodies.

Related Posts (10)  COMNAVAIRFORINST 4790.2B PDF

Hashimoto’s encephalopathy is a rare condition associated with Hashimoto thyroiditis, the presence of high concentrations of anti-thyroid antibodies, without any evidence of thyroid dysfunction, and an excellent response to treatment with corticosteroids 2.

Insomnia Hypersomnia Sleep apnea Obstructive Congenital central hypoventilation syndrome Narcolepsy Cataplexy Kleine—Levin Circadian hashmoto sleep disorder Advanced sleep phase disorder Delayed sleep phase disorder Nonhour sleep—wake disorder Jet lag.

The dose of steroid was gradually reduced. All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.

Encefalopatia de Hashimoto | SPEDM Journal

Because most patients respond to steroids or immunosuppressant treatment, this condition is now also referred to as steroid -responsive encephalopathy. It was suggested that the hypocampus, hypothalamus and hair follicles form a molecular target for auto-immunity, the so-called ‘triple H’ syndrome 6.

Eight years ago she developed hypothyroidism due to Hashimoto’s thyroiditis, and has been taking mcg levothyroxine daily.

The patients met the clinical criteria for Creutzfeldt-Jakob disease and were notified 8. The rest of the physical examination was normal.

The mechanism of pathogenesis is not known but it has been hypothesized to be an autoimmune disorder, similar to Hashimoto’s thyroiditis as its name suggests.

Hashimoto’s encephalopathy mimicking Creutzfeldt-Jakob disease: In an epidemiological study made by Seipelt et al. She was maintained on oral prednisolone.

Encefalopayia herniation Reye’s Hepatic encephalopathy Toxic encephalopathy Hashimoto’s encephalopathy. However, the role of those antibodies and their pathophysiology are unknown. MRI and cerebral angiography are normal in the majority of cases 2.

Related Posts (10)  DISGO NET BROWSER 3000 MANUAL PDF

Anti-thyroperoxidase antibodies anti-TPO was 1. The clinical manifestations can be fluctuating or persistent, and reversible, if properly treated with immunosuppressive therapy 3. Hashimoto’s encephalopathyalso known as steroid responsive encephalopathy associated hashijoto autoimmune thyroiditis SREATis a neurological condition characterized by encephalopathythyroid autoimmunity, and good clinical response to steroids.

Hashimoto’s encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease. Japan, and Depannient of Anatomy and Biology. Hepato-toxicity led to the interruption of azathioprine in this case. Encephalitis Viral encephalitis Herpesviral encephalitis Limbic encephalitis Encephalitis lethargica Cavernous sinus thrombosis Brain abscess Amoebic.

Encefalopatia de Hashimoto

Services on Demand Journal. Infobox medical condition new All articles with unsourced statements Articles with unsourced statements from April Hashimoto’s encephalopathy with encefaloppatia features similar to those of Creutzfeldt-Jakob disease. Encephalomyelitis Acute disseminated Myalgic Meningoencephalitis. Hashimoto’s encephalitis HEencephalitis which encefallopatia to steroids and is associated with auto-immune thyroiditis, was described by Brain et al.

From Wikipedia, the free encyclopedia. Prion diseases are under compulsory notification in Brazil: Consistent with this hypothesis, autoantibodies to alpha-enolase have been found to be associated with Hashimoto’s encephalopathy.

Very little is known about the pathology of Hashimoto’s encephalopathy. Some aspects warrant particular attention: Since then, Hashimoto’s encephalopathy encefalpoatia been recognized as a rare condition associated to Hashimoto’s thyroiditis and to the presence of high concentrations of antithyroid antibodies, unlike those described in myxedema and in thyrotoxicosis 2.